62 related articles for article (PubMed ID: 10408399)
1. Mutations in Bcl10 are very rare in colorectal cancer.
Stone JG; Rowan AJ; Tomlinson IP; Houlston RS
Br J Cancer; 1999 Jul; 80(10):1569-70. PubMed ID: 10408399
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene.
Yamada K; Zhong X; Kanazawa S; Koike J; Tsujita K; Hemmi H
Oncol Rep; 2003; 10(4):859-66. PubMed ID: 12792735
[TBL] [Abstract][Full Text] [Related]
3. No evidence for BCL10 mutation in endometrial cancers with microsatellite instability.
Cohn D; Mutch D; Elbendary A; Rader J; Herzog T; Goodfellow P
Hum Mutat; 2001 Feb; 17(2):117-21. PubMed ID: 11180594
[TBL] [Abstract][Full Text] [Related]
4. BCL10 is rarely mutated in human prostate carcinoma, small-cell lung cancer, head and neck tumours, renal carcinoma and sarcomas. MPT Collaborators, St George's Hospital Collaborators.
Gill S; Broni J; Jefferies S; Osin P; Kovacs G; Maitland NJ; Eeles R; Edwards SM; Dyer MJ; Willis TG; Cooper CS
Br J Cancer; 1999 Jul; 80(10):1565-8. PubMed ID: 10408398
[TBL] [Abstract][Full Text] [Related]
5. The apoptotic regulatory gene, BCL10, is mutated in sporadic mismatch repair deficient colorectal cancers.
Simms LA; Young J; Wicking C; Meltzer SJ; Jass JR; Leggett BA
Cell Death Differ; 2000 Feb; 7(2):236-7. PubMed ID: 10819599
[No Abstract] [Full Text] [Related]
6. Lack of Bcl10 gene mutations in laryngeal squamous cell carcinoma.
Ronchetti D; Intini D; Pruneri G; Neri A; Pignataro L
J Laryngol Otol; 2002 Aug; 116(8):610-2. PubMed ID: 12389689
[TBL] [Abstract][Full Text] [Related]
7. Lack of Bcl10 mutations in testicular germ cell tumours and derived cell lines.
van Schothorst EM; Mohkamsing S; van Gurp RJ; Oosterhuis JW; van der Saag PT; Looijenga LH
Br J Cancer; 1999 Jul; 80(10):1571-4. PubMed ID: 10408400
[TBL] [Abstract][Full Text] [Related]
8. SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway.
Woodford-Richens KL; Rowan AJ; Gorman P; Halford S; Bicknell DC; Wasan HS; Roylance RR; Bodmer WF; Tomlinson IP
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9719-23. PubMed ID: 11481457
[TBL] [Abstract][Full Text] [Related]
9. BCL10 in malignant lymphomas--an evaluation using fluorescence in situ hybridization.
Achuthan R; Bell SM; Carr IM; Leek JP; Roberts P; Horgan K; Markham AF; Selby PJ; MacLennan KA
J Pathol; 2002 Jan; 196(1):59-66. PubMed ID: 11748643
[TBL] [Abstract][Full Text] [Related]
10. Detection of point mutations of BCL10 gene in hepatocellular carcinoma tissues: report of 46 cases.
Jihua C; Xisheng L; Shengli C; Zongxian C; Guang C; Ruyu D
Hum Mutat; 2000 May; 15(5):482-3. PubMed ID: 10790217
[TBL] [Abstract][Full Text] [Related]
11. Lack of BCL10 mutations in multiple myeloma and plasma cell leukemia.
Shih LY; Fu JF; Shurtleff SA; Morris SW; Downing JR
Genes Chromosomes Cancer; 2001 Apr; 30(4):402-6. PubMed ID: 11241793
[TBL] [Abstract][Full Text] [Related]
12. Point mutations and deletions of the Bcl10 gene in solid tumors and malignant lymphomas.
Lee SH; Shin MS; Kim HS; Park WS; Kim SY; Lee HK; Park JY; Oh RR; Jang JJ; Park KM; Han JY; Kang CS; Lee JY; Yoo NJ
Cancer Res; 1999 Nov; 59(22):5674-7. PubMed ID: 10582682
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients.
Shin KH; Park YJ; Park JG
Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536
[TBL] [Abstract][Full Text] [Related]
14. Lack of Bcl10 mutations in malignant cartilaginous tumors.
Park YK; Park HR; Kim YW; Chi SG; Unni KK
Int J Mol Med; 2002 Mar; 9(3):217-9. PubMed ID: 11836626
[TBL] [Abstract][Full Text] [Related]
15. Bcl10 is not a target for frequent mutation in human carcinomas.
Lambers AR; Gumbs C; Ali S; Marks JR; Iglehart JD; Berchuck A; Futreal PA
Br J Cancer; 1999 Jul; 80(10):1575-6. PubMed ID: 10408401
[TBL] [Abstract][Full Text] [Related]
16. Inverse correlation between RER+ status and p53 mutation in colorectal cancer cell lines.
Cottu PH; Muzeau F; Estreicher A; Fléjou JF; Iggo R; Thomas G; Hamelin R
Oncogene; 1996 Dec; 13(12):2727-30. PubMed ID: 9000147
[TBL] [Abstract][Full Text] [Related]
17. Absence of post-transcriptional RNA modifications of BCL10 in human malignant mesothelioma and colorectal cancer.
Apostolou S; Murthy SS; Kolachana P; Jhanwar SC; Testa JR
Genes Chromosomes Cancer; 2001 Jan; 30(1):96-8. PubMed ID: 11107182
[TBL] [Abstract][Full Text] [Related]
18. Bcl10 mutations in malignancy.
Dyer MJ
Br J Cancer; 1999 Jul; 80(10):1491. PubMed ID: 10408386
[No Abstract] [Full Text] [Related]
19. Absence of Bcl10 gene mutations in Ewing's sarcomas.
Park YK; Chi SG; Unni KK
Oncol Rep; 2001; 8(6):1333-5. PubMed ID: 11605060
[TBL] [Abstract][Full Text] [Related]
20. Mutational and expressional analysis of a haploinsufficient tumor suppressor gene DOK2 in gastric and colorectal cancers.
An CH; Kim MS; Yoo NJ; Lee SH
APMIS; 2011 Aug; 119(8):562-4. PubMed ID: 21749457
[No Abstract] [Full Text] [Related]
[Next] [New Search]
